Poland· PL-100486141
Octenisept
A octenidin, kombinationen product containing octenidini dihydrochloridum + phenoxyethanolum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Octenidin, kombinationen is registered in 4 of 19 countries.
Countries holding a registration under ATC D08AJ57 (octenidin, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Octenidin, kombinationen · ATC D08AJ57
4 / 19 countries
- Czechiaprice
- Finlandprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Octenidini dihydrochloridum + Phenoxyethanolum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D08AJ57
- ATC class
- Octenidin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991729141
- gtin05909991729158
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D08AJ57
Octenidin, kombinationen, as other registers publish it.
- PolandActisept MEDPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- PolandActisept MEDPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- PolandDichlorowodorek oktenidyny + Fenoksyetanol LavipharmTaw Pharma (Ireland) Limited
- PolandHelp4Skin SEPTI-SPRAYZakłady Farmaceutyczne POLPHARMA S.A.
- PolandiladiamedAflofarm Farmacja Polska Sp. z o.o.
- PolandLinosepticDr. August Wolff GmbH & Co. Arzneimittel
- PolandLinosepticDr. August Wolff GmbH & Co. Arzneimittel
- PolandMaxisepticBausch Health Ireland Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2d0bb13-1d11-40da-a867-4f9c45823ec1 GET /v1/drugs/f2d0bb13-1d11-40da-a867-4f9c45823ec1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór na skórę",
"source": "urpl",
"strength": "(0,10 g + 2,00 g)/100 g",
"packaging": "05909991729141 ¦ OTC ¦ 150854\n1 butelka 50 ml\n05909991729158 ¦ OTC ¦ 150855\n1 butelka 250 ml",
"substance": "Octenidini dihydrochloridum 0.1 g/100 g + Phenoxyethanolum 2 g/100 g",
"common_name": "Octenidini dihydrochloridum + Phenoxyethanolum",
"pl_product_id": "100486141",
"pozwolenie_nr": "154/23",
"auth_procedure": "IR",
"authorisation_validity": "2028-07-31"
}See everything about octenidin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.